Drug trial aims to stop Surgery's hidden killer: organ failure
Prevention
Ongoing
This study is testing if a drug called Dalargin can prevent serious organ damage in patients recovering from major abdominal surgery, like stomach or colon operations. About 200 patients will be randomly assigned to receive either Dalargin or a placebo (saltwater) infusion for th…
Phase: PHASE3 • Sponsor: Botkin Hospital • Aim: Prevention
Last updated Mar 17, 2026 13:09 UTC